期刊文献+

siRNA干扰对变形链球菌耐氟菌ffh基因产酸能力的影响 被引量:3

Effect of siRNA Interference on the Acidogenicity for Gene ffh of Fluoride Resistant Streptococcus Mutans
下载PDF
导出
摘要 目的:探讨变形链球菌耐氟菌(UA159-FR)ffh基因siRNA干扰后对产酸能力的影响。方法:电穿孔法将siRNA转入UA159-FR与ffh基因序列靶向位点结合,将干扰前后细菌分别加入BHI培养液,含5%糖类的葡萄糖、蔗糖、乳糖、淀粉中培养,pH调至7.5,24h后测终末pH。结果:转染结果成功;干扰前后不同糖培养基中变形链球菌耐氟菌ffh基因对产酸有显著差异(P<0.05);干扰前后在常规、葡萄糖、及乳糖中差异极显著(P<0.01);蔗糖中差异显著(P<0.05);淀粉中无显著差异。结论:变形链球菌耐氟菌中基因ffh对产酸能力影响显著。 Objective: To have a discussion on the effect on the acidogenicity for gene ffh of fluoride resistant strep-tococcus mutans (UA159-FR)after siRNA interference. Methods.. UA159-FR was transformed by using electro-poration and combined with targeted site of ffh gene sequence, and cultured by adding BHI, glucose, saccharose, lactose and starch with 5 % saccharides into bacteria that was before interfered and after interfered respectively. PH was set to 7.5. The terminal PH was measured after 24 hours. Results: After the transfection, the result turned out to be successful. Before and after interference, there were some significant differences for transfection of fluoride resistant streptococcus mutans among different culture media of gene ffh (P〈0. 05).△NPH of normal, glucose and lactose were significantly different before and after the interference(P〈0.01) ; It was significant in sucrose(P〈0.05) and there was no obvious difference in starch. Conclusion: The effect of siRNA interference on the acidogenic- ity for gene ffh of fluoride resistant streptococcus mutans is significant.
出处 《口腔医学研究》 CAS CSCD 北大核心 2015年第2期105-108,共4页 Journal of Oral Science Research
基金 国家自然科学基金(3A411X463431)
关键词 变形链球菌耐氟 ffh基因 SIRNA 产酸能力 Fluoride resistant streptococcus mutans ffh gene siRNA Acidogenicity
  • 相关文献

参考文献3

二级参考文献22

  • 1严燕国,詹文华,赵刚,马晋平,蔡世荣.SiRNA特异性抑制幽门螺杆菌CagA基因表达的实验研究[J].中国人兽共患病学报,2006,22(4):330-333. 被引量:2
  • 2Miyashita T,Reed JC.Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line.Blood,1993;81(1):151-169.
  • 3Lowe SW,Bodis S,McClatchey A,et al.p53 statues and theefficacy of cancer therapy in vivo.Science,1994;266(5186):807-810.
  • 4Schmitt CA,Lowe SW.Bcl-2 mediates chemoresistance inmatched pairs of primary E(mu)-myc lymphomas in vivo.BloodCells Mol Dis,2001;27(1):206-216.
  • 5Schmitt CA,Rosenthal CT,Lowe SW.Genetic analysis ofchemoresistance in primary marine Lymphomas.Nat Med,2000;6(9):1029-1035.
  • 6Pennati M,Folini M,Zaffaroni N.Targeting survivin in cancertherapy:fulfilled promises and open questions.Carcinogenesis,2007;28(6):1133-1139.
  • 7CoiffierB,Lepage E,Briere J,et al.CHOP chemotherapy plusrituximab compared with CHOP alone in elderly patients withdiffuse large-B-cell lymphoma.N Engl J Med,2002;346(4):235-242.
  • 8Pfreundschuh M,Trumper L,Osterborg A,et al.CHOP-likechemotherapy plus rituximab versus CHOP-like chemotherapy alonein young patients with good-prognosis diffuse large-B-cell lym-phoma:a randomized controlled trial by the MabThera InternationalTrial(MInT)Group.Lancet Oncol,2006;7(5):379-391.
  • 9Feugier P,Van Hoof A,Sebban C,et al.Long-term results of theR-CHOP study in the treatment of elderly patients with diffuse largeB-cell lymphoma:a study by the Grouped“Etude des Lymphomasde l”Adulte.J Clin Oncol,2005;23(8):4117-4126.
  • 10Habermann TM,Weller EA,Morrison VA,et al.Rituximab-CHOP versus CHOP alone orwithmaintenance rituximab in olderpatients with diffuse large B-cell lymphoma.J Clin Oncol,2006;24(19):3121-3127.

共引文献49

同被引文献9

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部